Trending News

Novartis Talks Move to Cell and Gene Therapies at

Following a strong post-hoc analysis of mid-stage data in the fall of 2018, Novartis announced this
Read More

Pick the Commish: Voters advance FDA vets, includi

Fierce Pharma's search for a voter-crowned FDA commissioner has narrowed to an Elite Eight squad of
Read More

Call it a pandemic reckoning: New ESG expectations

Sanofi launched a nonprofit unit last week specifically set up to get its medicines to more people i
Read More

Bayer pairs its products in first-ever portfolio T

Bayer is taking on myths about intrauterine devices (IUDs) in a new two-product ad campaign. The fir
Read More

Does Vaccinating Against Rotavirus Also Protect Ag

The rotavirus vaccine may be pulling double duty; it not only protects young children against a pote
Read More

Roche to buy gene therapy firm Spark for $4.8 bill

Roche is to buy gene therapy firm Spark Therapeutics for $4.8 billion, adding an already-approved tr
Read More

Novartis pays $150M to license Akcea-Ionis cardiac

Novartis has taken up its option to license antisense oligonucleotide TQJ230, triggering a $150 mill
Read More


;